These data suggest that HLA-E has a mainly inhibitory function in HCC, and that the NKG2A/HLA-E interaction may act as a resistance mechanism as a result of repeated activation of the immune system in the tumor microenvironment. This evidence concerns the gene KLRC1 and hepatocellular carcinoma.